Evidence map›Paper›PMID 42693363›Full record

ArticleJournal of cancer survivorship : research and practice2026

Activity profiles and their correlates in patients with localised renal and colorectal cancer shortly after treatment: a cross-sectional analysis.

Annemone Siffels, Martijn J L Bours, Eline H van Roekel, Matty P Weijenberg, J P Michiel Sedelaar, Stéphanie O Breukink, Eric T P Keulen, Maryska Janssen-Heijnen, Koen G Frenken, Katja K H Aben and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Annemone SiffelsIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Martijn J L BoursDepartment of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Eline H van RoekelDepartment of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Matty P WeijenbergDepartment of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
J P Michiel SedelaarDepartment of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Stéphanie O BreukinkDepartment of Surgery, GROW Research Institute for Oncology and Reproduction, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Eric T P KeulenDepartment of Internal Medicine and Gastroenterology, Zuyderland Medical Centre Sittard-Geleen, Geleen, The Netherlands.
Maryska Janssen-HeijnenDepartment of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Koen G FrenkenDepartment of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Katja K H AbenIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Jake S F MauritsIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Lambertus A L M KiemeneyIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Laurien M BuffartDepartment of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Alina VrielingIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands. alina.vrieling@radboudumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study is to identify activity profiles and their correlates in patients with localised renal cell carcinoma (RCC) and colorectal cancer (CRC) shortly after treatment completion.

methodsIn the ReLife (n = 326 patients with RCC) and EnCoRe (n = 358 patients with CRC) studies, we measured physical activity and sedentary behaviour at 3 months and 6 weeks after treatment completion using accelerometers. We used latent profile analyses to determine activity profiles. Demographic, lifestyle-related, and clinical correlates were investigated with multinomial regression analyses.

resultsWe identified three activity profiles for both populations: a most sedentary (RCC:28%, CRC:16%), an average (RCC:50%, CRC:53%), and a highly active profile (RCC:22%, CRC:31%). In the most sedentary profile, mean sedentary time was 11.9 h/day for RCC and 13.1 h/day for CRC, while mean physical activity was 72 min/day and 44 min/day, respectively. Correlates of the most sedentary profile were male sex (RCC: odds ratio (OR), 2.18; 95% confidence interval [95%CI], 1.06-4.47), and higher fatigue scores (per 1 point: RCC, 0.98 [0.96-1.00]; CRC, 0.98 [0.96-0.99]). Correlates of the highly active profile were male sex (CRC, 0.38 [0.20-0.71]), higher educational level (RCC, 0.31 [0.14-0.72]; CRC, 0.46 [0.22-0.96]), and higher BMI (per 1 kg/m

conclusionsThere are distinct activity profiles in patients with RCC and CRC. Male sex, higher education, higher BMI, and lower fatigue score were associated with less favourable profiles. IMPLICATIONS FOR CANCER SURVIVORS: These findings highlight that activity profiles in patients with RCC and CRC are heterogeneous, which should be considered when promoting healthy lifestyles.

Indexed as

Cancer survivorshipColorectal cancerLifestylePhysical activityRenal cell carcinomaSedentary behaviour

Identifiers

PMID42693363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.